Vancomycin dosing in children: what is the question?
- PMID: 23956256
- DOI: 10.1136/archdischild-2013-304169
Vancomycin dosing in children: what is the question?
Abstract
Vancomycin has been in clinical use for over 60 years, but it is still not clear what dose should be given to children. Effective treatment with vancomycin requires a serum concentration well above the minimum inhibitory concentration (MIC) of the bacteria being treated. This is predicted by the area under the concentration curve (AUC) divided by the MIC being >400 (AUC/MIC). Recent concerns about increasing MIC in staphylococci have lead to recommendations to aim for higher trough vancomycin levels (15-20 mg/L). In current practice, most children do not achieve these trough levels. Modelling and pharmacokinetic studies in children suggest these trough levels may not be necessary if the MIC of the organisms is 1 mg/L or less. Further, large-scale studies are needed to determine the most appropriate dosing of vancomycin in children. While awaiting these, it is time to consider moving to 15 mg/kg 6 h as a standard starting regime for vancomycin. It is also vital to determine the MIC of the organism being treated, as this may give some guidance about suitable trough levels to be aimed for. There is currently little evidence to guide the use of loading doses or continuous vancomycin infusions in children.
Keywords: Infectious Diseases; Microbiology; Pharmacology.
Similar articles
-
Vancomycin serum concentrations in pediatric oncologic/hematologic intensive care patients.Braz J Infect Dis. 2012 Jul-Aug;16(4):361-5. doi: 10.1016/j.bjid.2012.06.011. Braz J Infect Dis. 2012. PMID: 22846125
-
AUC versus peak-trough dosing of vancomycin: applying new pharmacokinetic paradigms to an old drug.Ther Drug Monit. 2013 Aug;35(4):443-9. doi: 10.1097/FTD.0b013e31828b2a50. Ther Drug Monit. 2013. PMID: 23851909 Review.
-
Desired vancomycin trough serum concentration for treating invasive methicillin-resistant Staphylococcal infections.Pediatr Infect Dis J. 2013 Oct;32(10):1077-9. doi: 10.1097/INF.0b013e318299f75c. Pediatr Infect Dis J. 2013. PMID: 23652479
-
The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion.J Clin Pharm Ther. 2015 Jun;40(3):259-65. doi: 10.1111/jcpt.12270. Epub 2015 Apr 11. J Clin Pharm Ther. 2015. PMID: 25865426 Review.
-
Balancing vancomycin efficacy and nephrotoxicity: should we be aiming for trough or AUC/MIC?Paediatr Drugs. 2015 Apr;17(2):97-103. doi: 10.1007/s40272-015-0117-5. Paediatr Drugs. 2015. PMID: 25644329
Cited by
-
Effective vancomycin concentrations in children: a cross-sectional study.Einstein (Sao Paulo). 2019 Feb 14;17(1):eAO4396. doi: 10.31744/einstein_journal/2019AO4396. Einstein (Sao Paulo). 2019. PMID: 30785491 Free PMC article.
-
Early Bayesian Dose Adjustment of Vancomycin Continuous Infusion in Children: a Randomized Controlled Trial.Antimicrob Agents Chemother. 2019 Sep 9;63(12):e01102-19. doi: 10.1128/AAC.01102-19. Epub 2019 Oct 7. Antimicrob Agents Chemother. 2019. PMID: 31591117 Free PMC article.
-
Review of vancomycin-induced renal toxicity: an update.Ther Adv Endocrinol Metab. 2016 Jun;7(3):136-47. doi: 10.1177/2042018816638223. Epub 2016 Mar 30. Ther Adv Endocrinol Metab. 2016. PMID: 27293542 Free PMC article. Review.
-
Management of early- and late-onset sepsis: results from a survey in 80 German NICUs.Infection. 2019 Aug;47(4):557-564. doi: 10.1007/s15010-018-1263-9. Epub 2019 Jan 3. Infection. 2019. PMID: 30607897
-
Anti-infective use in children and pregnancy: current deficiencies and future challenges.Br J Clin Pharmacol. 2015 Feb;79(2):216-21. doi: 10.1111/bcp.12363. Br J Clin Pharmacol. 2015. PMID: 24588467 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical